(SCHB) Schwab U.S. Broad Market - Overview
Etf: Stocks, 2500 Companies, US Listed, Liquid Holdings
Dividends
| Dividend Yield | 1.20% |
| Yield on Cost 5y | 1.95% |
| Yield CAGR 5y | -32.02% |
| Payout Consistency | 99.0% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 15.0% |
| Relative Tail Risk | 4.63% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.61 |
| Alpha | -0.21 |
| Character TTM | |
|---|---|
| Beta | 0.958 |
| Beta Downside | 0.965 |
| Drawdowns 3y | |
|---|---|
| Max DD | 19.34% |
| CAGR/Max DD | 1.05 |
Description: SCHB Schwab U.S. Broad Market January 29, 2026
Schwab’s U.S. Broad Market ETF (SCHB) seeks to track a market-cap-weighted index that includes the 2,500 largest U.S. equities with readily available pricing. By law the fund must hold at least 90 % of its net assets in those index constituents, allowing a maximum of 10 % in non-index securities for cash management or tactical positioning.
As of the most recent quarterly report (Q4 2025), SCHB manages roughly $27 billion in assets, carries an expense ratio of 0.03 % (one of the lowest in the large-blend space), and reports a 30-day SEC yield of about 1.7 %. The top sector exposures are Technology (≈22 % of assets), Health Care (≈13 %), and Consumer Discretionary (≈12 %). Over the trailing 12 months the fund delivered a total return of +10.4 % versus the S&P 500’s +9.8 %, reflecting its broader coverage of mid-cap and small-cap stocks. Turnover remains modest at roughly 12 % annually, indicating a largely passive strategy.
For a deeper quantitative dive-including factor exposures, risk-adjusted performance, and scenario analysis-consider exploring the SCHB profile on ValueRay.
What is the price of SCHB shares?
Over the past week, the price has changed by -0.45%, over one month by +0.19%, over three months by +2.00% and over the past year by +15.00%.
Is SCHB a buy, sell or hold?
What are the forecasts/targets for the SCHB price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 31.1 | 16.5% |
SCHB Fundamental Data Overview February 04, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 38.86b USD (38.86b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 38.86b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 38.86b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 9.45% (E(38.86b)/V(38.86b) * Re(9.45%) + (debt-free company))
Discount Rate = 9.45% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)